Flexion Therapeutics Reports First-Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Flexion Therapeutics (FLXN) Tops Q1 EPS by 13c
May 7, 2015 4:58 PM EDTFlexion Therapeutics (NASDAQ: FLXN) reported Q1 EPS of ($0.43), $0.13 better than the analyst estimate of ($0.56).
As of March 31, 2015, the company had $137.4 million in cash, cash equivalents, and marketable securities compared to $151.6 million as of December 31, 2014.
"The team at Flexion was clearly... More



